NSI 532 IGF
Alternative Names: HK 532 IGF1; NSI-532-IGF; NSI-532.IGF; NSI-532.IGF1Latest Information Update: 29 Apr 2021
At a glance
- Originator Neuralstem
- Developer Palisade Bio
- Class Antidementias; Neural stem cell therapies; Neuroprotectants
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 27 Apr 2021 Leading BioSciences has merged with Seneca Biopharma to form Palisade Bio
- 28 Nov 2020 No recent reports of development identified for preclinical development in Alzheimer's-disease in USA (Intracerebral, Injection)
- 28 Oct 2019 Neuralstem is now called Seneca Biopharma